Cetera Advisor Networks’s Genmab GMAB Stock Holding History

Cetera Advisor Networks’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$267K	Buy	8,920 +122	+1%	+$3.58K	﹤0.01%	2375
2023 Q4	$280K	Sell	8,798 -1,101	-11%	-$34.6K	﹤0.01%	2292
2023 Q3	$349K	Buy	+9,899	New	+$377K	﹤0.01%	2034
2023 Q1	–	Sell	-11,671	Closed	-$495K	–	2633
2022 Q4	$495K	Buy	+11,671	New	+$481K	﹤0.01%	1654
2020 Q3	–	Sell	-199	Closed	-$7K	–	1935
2020 Q2	$7K	Buy	+199	New	+$5.42K	﹤0.01%	2855

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Advisor Networks's GMAB Position: Q1 2024 in Review

Cetera Advisor Networks increased its Genmab (GMAB) stake by 1.4% in Q1 2024, buying an estimated $3.58K and bringing the position to 8,920 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

Cetera Advisor Networks first reported a position in GMAB in Q2 2020 and has held it in 5 quarters since. The position peaked at $495K in Q4 2022. 228 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

Cetera Advisor Networks held 8,920 shares of Genmab worth $267K as of Q1 2024.
Cetera Advisor Networks bought 122 Genmab shares in Q1 2024, an estimated $3.58K.
Genmab made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2375 holding.
Cetera Advisor Networks first reported a position in Genmab in Q2 2020 and has held it in 5 quarters since.
Cetera Advisor Networks's Genmab position peaked at $495K in Q4 2022.
228 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.